FDA Approved: ERIVEDGE — Supplemental Application (Genentech, Inc.)

View source ↗

Summary

The FDA approved Genentech's supplemental application for ERIVEDGE (vismodegib). The action updates the product's labeling and indications for basal cell carcin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Basal Cell Carcinoma

Drugs mentioned

• Erivedge (vismodegib)

Snippet

SUPPL AP for ERIVEDGE (VISMODEGIB)